Baker Avenue Asset Management, LP Bio Techne Corp Transaction History
Baker Avenue Asset Management, LP
- $3.56 Billion
- Q4 2024
Shares
3 transactions
Others Institutions Holding TECH
# of Institutions
619Shares Held
156MCall Options Held
161KPut Options Held
12.7K-
Vanguard Group Inc Valley Forge, PA18.6MShares$1.14 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15MShares$917 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.7MShares$652 Million0.09% of portfolio
-
State Street Corp Boston, MA6.47MShares$396 Million0.02% of portfolio
-
Morgan Stanley New York, NY4.76MShares$291 Million0.02% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $2.4B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...